EUVIMEDEUVIMED entdecken
Crossref

Toosendanin alleviates acute lung injury by reducing pulmonary vascular barrier dysfunction mediated by endoplasmic reticulum stress through mTOR

Xiaocheng Mao, Cheng Wang, Hong Tang, Xiaohua Liu, Caihui Wei, Fang Yin, Tianmei Fu, Yangyang Fang, Kuai Yu, Zhanglin Zhang, Chenggao Wu, Hongfei Liu und 1 weitere

Phytomedicine · 2025-01 · 136 · 156277

DOI: 10.1016/j.phymed.2024.156277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025-01. Verfasst von Xiaocheng Mao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, Key Laboratory of Jiangxi Province for Transfusion Medicine, the First Affiliated Hospital, Jiangxi Medical College,…. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, TOR Serine-Threonine Kinases, Acute Lung Injury, Drugs, Chinese Herbal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe clinical conditions with limited treatment options. Toosendanin (TSN), a triterpenoid compound with anti-inflammatory effects, has unclear efficacy in ALI. PURPOSE: This study aimed to evaluate TSN's protective effects on ALI and the related mechanisms. METHODS: Lipopolysaccharide (LPS)-induced ALI models were developed in vivo and in vitro. Endothelial permeability was measured using Evans Blue dye; lipid reactive oxygen species (ROS) and apoptosis were assessed using flow cytometry. Malondialdehyde (MDA) and superoxide dismutase (SOD) levels were determined, and cell viability was measured. mRNA and protein expression were quantified using qRT-PCR and Western blotting. Network pharmacology and surface plasmon resonance were used to identify and validate TSN's targets. RESULTS: TSN reduced endothelial permeability and LPS-induced ALI. It lowered ROS levels, lipid peroxidation, endoplasmic reticulum (ER) stress, and apoptosis, both in vitro and in vivo. Network pharmacology identified mTOR as a key target of TSN, and surface plasmon resonance analysis confirmed TSN's direct binding to mTOR, underscoring mTOR's role in TSN's protective effects against ALI. Western blotting showed that TSN inhibits mTOR and its phosphorylation. In vitro, the mTOR activator MHY1485 reversed TSN's protective effects, increasing ER stress, apoptosis, and endothelial permeability. In vivo, TSN and rapamycin synergistically protected against ALI. CONCLUSION: This study is the first to demonstrate that TSN protects against ALI by targeting the mTOR pathway, regulating ER stress and apoptosis and mitigating endothelial damage. These findings suggest a novel approach for ALI treatment and underscore TSN's potential clinical value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoplasmic Reticulum StressTOR Serine-Threonine KinasesAcute Lung InjuryDrugs, Chinese HerbalAnimalsApoptosisMaleReactive Oxygen SpeciesHumansLipopolysaccharidesCapillary PermeabilityMiceLungDisease Models, AnimalLipid PeroxidationMice, Inbred C57BLTriterpenes

Stichwörter der Autor:innen

Acute lung injuryEndoplasmic reticulum stressEndothelial cellsToosendaninmTOR

Substanzen

TOR Serine-Threonine KinasestoosendaninReactive Oxygen SpeciesDrugs, Chinese HerbalLipopolysaccharidesTriterpenes

Autor:innen und Institutionen

  • Department of Blood Transfusion, Key Laboratory of Jiangxi Province for Transfusion Medicine, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, PR China.
  • Department of Critical Care Medicine, Medical Center of Anesthesiology and Pain, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, PR China.
  • Department of Blood Transfusion, Key Laboratory of Jiangxi Province for Transfusion Medicine, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, PR China. Electronic address:…

Zitieren

APA

Mao, X., Wang, C., Tang, H., Liu, X., Wei, C., Yin, F., Fu, T., Fang, Y., Yu, K., Zhang, Z., Wu, C., Liu, H., & Le, A. (2025). Toosendanin alleviates acute lung injury by reducing pulmonary vascular barrier dysfunction mediated by endoplasmic reticulum stress through mTOR. Phytomedicine, 136, 156277. https://doi.org/10.1016/j.phymed.2024.156277

Vancouver

Mao X, Wang C, Tang H, Liu X, Wei C, Yin F, et al. Toosendanin alleviates acute lung injury by reducing pulmonary vascular barrier dysfunction mediated by endoplasmic reticulum stress through mTOR. Phytomedicine. 2025;136:156277. doi:10.1016/j.phymed.2024.156277

BibTeX
@article{Mao2025,
  author = {Mao, Xiaocheng and Wang, Cheng and Tang, Hong and Liu, Xiaohua and Wei, Caihui and Yin, Fang and Fu, Tianmei and Fang, Yangyang and Yu, Kuai and Zhang, Zhanglin and Wu, Chenggao and Liu, Hongfei and Le, Aiping},
  title = {Toosendanin alleviates acute lung injury by reducing pulmonary vascular barrier dysfunction mediated by endoplasmic reticulum stress through mTOR},
  journal = {Phytomedicine},
  year = {2025},
  volume = {136},
  pages = {156277},
  doi = {10.1016/j.phymed.2024.156277}
}
Kostenlos starten →